Molecular Carcinogenesis of Endometrial Cancer

This publication has 50 references indexed in Scilit:

• Combined E-cadherin, alpha-catenin, and beta-catenin expression is a favorable prognostic factor in endometrial carcinoma
  International Journal of Gynecologic Cancer, 2006
• Low frequency of BRAF and CDKN2A mutations in endometrial cancer
  International Journal of Cancer, 2005
• THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASE
  Annual Review of Cell and Developmental Biology, 2004
• Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers
  Oncogene, 2003
• β-Catenin and E-Cadherin Expression Patterns in High-Grade Endometrial Carcinoma Are Associated with Histological Subtype
  Laboratory Investigation, 2002
• PTEN, a Protean Tumor Suppressor
  The American Journal of Pathology, 2001
• p53 Mutation Is Infrequent in Clear Cell Carcinoma of the Ovary
  Gynecologic Oncology, 2001
• MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas
  Oncogene, 1998
• Case--Control Study of Endogenous Steroid Hormones and Endometrial Cancer
  JNCI Journal of the National Cancer Institute, 1996
• KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2
  Science, 1995